| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.3 | 2e-11 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |